Skip to main content
Equibles

Corient Private Wealth LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1948780 MIAMI, FL
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 27, 2026
Position Value
$104,720
+$53,120 QoQ
Shares Held
37,400
+87.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 62 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $248,190,979 across 122 Biotechnology names. ANIX ranks #102 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 103,755 $51,538,220
2 IONS
Ionis Pharmaceuticals Inc
 196,661 $15,593,250
3 HALO
Halozyme Therapeutics, Inc.
 187,166 $14,649,482
4 KRYS
Krystal Biotech, Inc.
 30,558 $11,357,491
5 TECH
BIO-TECHNE Corp
 119,590 $8,449,033
6 REGN
Regeneron Pharmaceuticals, Inc.
 12,473 $7,777,414
7 ALNY
Alnylam Pharmaceuticals, Inc.
 23,969 $7,215,387
8 CLDX
Celldex Therapeutics, Inc.
 176,956 $6,584,532

All Filings in ANIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $104,720 37,400
2026-03-31 $51,600 20,000
2025-12-31 $116,688 37,400
2025-09-30 $123,420 37,400
2025-06-30 $123,420 37,400
2025-03-31 $106,964 37,400
2024-12-31 $86,768 37,400
2024-09-30 $117,810 37,400
2024-06-30 $82,654 37,400
2024-03-31 $116,688 37,400
2023-12-31 $145,112 37,400
2023-09-30 $65,400 20,000
2023-06-30 $64,000 20,000
2023-03-31 $86,000 20,000
2022-12-31 $85,000 20,000